Henry Ji, Ph.D., co-founded Sorrento Therapeutics, Inc. in January 2006 and currently serves as the President and Chief Executive Officer. He also is a director and was the Chief Scientific Officer from November 2008 to August 2012. In 2002, Dr. Ji founded BioVintage, Inc., a research and development company focusing on innovative life science technology and product development and has served as its President since 2002.  From 2001 to 2002, Dr. Ji served as Vice President of CombiMatrix Corporation, a publicly traded biotechnology company developing and offering technologies applicable in drug development, genetic analysis and molecular diagnostics.  During his tenure at CombiMatrix, Dr. Ji was responsible for strategic technology alliances with biopharmaceutical companies.  From 1999 to 2001, Dr. Ji served as Director of Business Development, and in 2001 as Vice President, of Stratagene Corporation (acquired by Agilent Technologies, Inc.) a company that develops innovative products and technologies for life science research, where he was responsible for technology development and product licensing.  In 1997, Dr. Ji co-founded Stratagene Genomics, Inc., a wholly owned subsidiary of the Stratagene Corporation, and served as its President and CEO from its founding until 1999. Before, Dr. Ji was a research scientist with Human Genome Sciences, Inc.
Dr. Ji is the holder of several issued and pending patents in the life science research field and is the sole inventor of STI’s G-MAB® intellectual property. Dr. Ji holds a Ph.D. in Animal Physiology from the University of Minnesota and a B.S. in Biochemistry from Fudan University, China.